| Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11) |
139 |
| The IASP classification of chronic pain for ICD-11: chronic primary pain |
65 |
| Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies |
62 |
| The IASP classification of chronic pain for ICD-11: chronic neuropathic pain |
61 |
| Inflammation in the pathophysiology of neuropathic pain |
48 |
| Core outcome measurement instruments for clinical trials in nonspecific low back pain |
43 |
| Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain |
39 |
| Comparative transcriptome profiling of the human and mouse dorsal root ganglia: an RNA-seq-based resource for pain and sensory neuroscience research |
35 |
| The IASP classification of chronic pain for ICD-11: chronic postsurgical or posttraumatic pain |
31 |
| When pain gets stuck: the evolution of pain chronification and treatment resistance |
27 |
| Recommendations for selection of self-report pain intensity measures in children and adolescents: a systematic review and quality assessment of measurement properties |
27 |
| An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia |
26 |
| Neuroinflammation of the spinal cord and nerve roots in chronic radicular pain patients |
22 |
| Symptom perception, placebo effects, and the Bayesian brain |
21 |
| Microglial P2X(4)R-evoked pain hypersensitivity is sexually dimorphic in rats |
20 |
| Mesenchymal stem cell exosomes as a cell-free therapy for nerve injury-induced pain in rats |
20 |
| Interleukin-4 mediates the analgesia produced by low-intensity exercise in mice with neuropathic pain |
19 |
| Estimating minimally important differences for the PROMIS pain interference scales: results from 3 randomized clinical trials |
19 |
| Efficacy of the Na(v)1.7 blocker PF-05089771 in a randomised, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy |
18 |
| Chronic neuropathic pain reduces opioid receptor availability with associated anhedonia in rat |
17 |
| The relationship between catastrophizing and altered pain sensitivity in patients with chronic low-back pain |
17 |
| Surgical interventions for the treatment of painful neuroma: a comparative meta-analysis |
17 |
| Relationship between concomitant benzodiazepine-opioid use and adverse outcomes among US veterans |
17 |
| Use of prescription opioids before and after an operation for chronic pain (lumbar fusion surgery) |
17 |
| Quantitative sensory testing in patients with migraine: a systematic review and meta-analysis |
17 |
| Rare Na(V)1.7 variants associated with painful diabetic peripheral neuropathy |
17 |
| Alexithymia in individuals with chronic pain and its relation to pain intensity, physical interference, depression, and anxiety: a systematic review and meta-analysis |
16 |
| Kappa opioid signaling in the central nucleus of the amygdala promotes disinhibition and aversiveness of chronic neuropathic pain |
16 |
| Altered microbiome composition in individuals with fibromyalgia |
16 |
| Procedural pain and oral glucose in preterm neonates: brain development and sex-specific effects |
16 |
| Machine learning in pain research |
16 |
| Developing a core outcome domain set to assessing effectiveness of interdisciplinary multimodal pain therapy: the VAPAIN consensus statement on core outcome domains |
16 |
| Exercise-induced pain and analgesia? Underlying mechanisms and clinical translation |
16 |
| Sources of opioid medication for misuse in older adults: results from a nationally representative survey |
16 |
| Chronic exposure to insufficient sleep alters processes of pain habituation and sensitization |
15 |
| Analgesic effects of a novel pH-dependent mu-opioid receptor agonist in models of neuropathic and abdominal pain |
15 |
| Pain as a threat to the social self: a motivational account |
15 |
| Long-term changes in biopsychosocial characteristics related to temporomandibular disorder: findings from the OPPERA study |
15 |
| Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic noncancer pain: a randomized, double-blind, placebo-controlled phase 3 study |
15 |
| Why wait to address high-risk cases of acute low back pain? A comparison of stepped, stratified, and matched care |
15 |
| Pathophysiological mechanisms of neuropathic pain: comparison of sensory phenotypes in patients and human surrogate pain models |
15 |
| The IASP classification of chronic pain for ICD-11: chronic secondary visceral pain |
15 |
| The IASP classification of chronic pain for ICD-11: chronic secondary headache or orofacial pain |
15 |
| The IASP classification of chronic pain for ICD-11: functioning properties of chronic pain |
15 |
| Genetic studies of human neuropathic pain conditions: a review |
14 |
| Abnormal medial prefrontal cortex functional connectivity and its association with clinical symptoms in chronic low back pain |
14 |
| Machine learning based prediction of clinical pain using multimodal neuroimaging and autonomic metrics |
14 |
| Music-induced analgesia: how does music relieve pain? |
14 |
| Trajectories and predictors of the long-term course of low back pain: cohort study with 5-year follow-up |
14 |
| Pain as a risk factor for common mental disorders. Results from the Netherlands Mental Health Survey and Incidence Study-2: a longitudinal, population-based study |
14 |
